Cart
sales@molnova.com
Menin-MLL inhibitor 20
CAS No. 2448173-47-3
Menin-MLL inhibitor 20( —— )
Catalog No. M28660 CAS No. 2448173-47-3
Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 87 | In Stock |
|
| 5MG | 79 | In Stock |
|
| 10MG | 130 | In Stock |
|
| 25MG | 264 | In Stock |
|
| 50MG | 382 | In Stock |
|
| 100MG | 544 | In Stock |
|
| 200MG | 737 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMenin-MLL inhibitor 20
-
NoteResearch use only, not for human use.
-
Brief DescriptionMenin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6).
-
DescriptionMenin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
Recptorγ-secretase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2448173-47-3
-
Formula Weight612.72
-
Molecular FormulaC33H40N8O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 33.33 mg/mL (54.40 mM)
-
SMILESCC(C)(C)OC(N[C@H]1CN(Cc2cc(C(Nc(cc3)ccc3-c([nH]3)cc4c3ncnc4N3CCOCC3)=O)ncc2)CCC1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhao B, et al. Identification of gamma-secretase inhibitor potency determinants on presenilin. J Biol Chem. 2008 Feb 1;283(5):2927-38.
molnova catalog
related products
-
CCT077791
CCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
-
SMARCA-BD ligand 1 f...
SMARCA-BD ligand 1 for Protac is a compound that binds to SMARCA2, the BAF ATPase subunit, utilizing Protac technology to degrade SMARCA2.
-
C-82
C-82 is a specific CBP/β-catenin antagonist. It inhibits the binding between β-catenin and CBP and increases the binding between β-catenin and p300.
